Literature DB >> 6174553

The psychopharmacological treatment of obsessive-compulsive disorder: a review.

T R Insel, D L Murphy.   

Abstract

This article reviews the literature concerning obsessive-compulsive disorder (OCD) and its treatment with drugs. We survey the differential diagnosis of OCD and the problems involved in evaluating its severity in a research setting. Pharmacological treatment of OCD has usually involved antidepressants, especially clomipramine, with equivocal but nevertheless encouraging success. Anxiolytic and neuroleptics have also been tried, but the results are inconsistent. We discuss the implications of these findings for treatment of patients with OCD and for future research.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174553     DOI: 10.1097/00004714-198109000-00006

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  4 in total

1.  Effects of yohimbine in obsessive compulsive disorder.

Authors:  S A Rasmussen; W K Goodman; S W Woods; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Obsessive Compulsive Disorder: Improving prognosis through therapy and drug treatment.

Authors:  V Goli; R Krishnan; E Ellinwood
Journal:  Can Fam Physician       Date:  1991-06       Impact factor: 3.275

3.  D-amphetamine in obsessive-compulsive disorder.

Authors:  T R Insel; J A Hamilton; L B Guttmacher; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Successful treatment of obsessive-compulsive disorder with zimelidine, a serotonin re-uptake inhibitor.

Authors:  A Prasad
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.